Evidence map›Paper›PMID 37606258›Full record

ArticleBioconjugate chemistry2023

Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target

Chiara Bellini, Emil Vergara, Fruzsina Bencs, Kinga Fodor, Szilvia Bősze, Denis Krivić, Bernadett Bacsa, Sára Eszter Surguta, József Tóvári, Rajko Reljic and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioconjugate chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Recent Characterization of Key Proteins to Combat Tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Chiara BelliniMTA-TTK Lendület "Momentum" Peptide-Based Vaccines Research Group, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Budapest 1117, Hungary.
Emil VergaraInstitute for Infection and Immunity, St. George's, University of London, London SW17 0RE, U.K.
Fruzsina BencsHevesy György PhD School of Chemistry, Eötvös Loránd University, Budapest 1117, Hungary.ORCID 0009-0003-9246-2228
Kinga FodorDepartment of Laboratory Animal Science and Animal Protection, University of Veterinary Medicine, Budapest 1078, Hungary.
Szilvia BőszeELKH-ELTE Research Group of Peptide Chemistry, Eötvös Loránd Research Network (ELKH), Eötvös Loránd University, Budapest 1117, Hungary.ORCID 0000-0001-9555-699X
Denis KrivićDivision of Medical Physics and Biophysics, Gottfried Schatz Research Center, Medical University of Graz, 8010 Graz, Austria.
Bernadett BacsaDivision of Medical Physics and Biophysics, Gottfried Schatz Research Center, Medical University of Graz, 8010 Graz, Austria.
Sára Eszter SurgutaDepartment of Experimental Pharmacology and National Tumor Biology Laboratory, National Institute of Oncology, Budapest 1122, Hungary.
József TóváriDepartment of Experimental Pharmacology and National Tumor Biology Laboratory, National Institute of Oncology, Budapest 1122, Hungary.
Rajko ReljicInstitute for Infection and Immunity, St. George's, University of London, London SW17 0RE, U.K.
Kata HorvátiMTA-TTK Lendület "Momentum" Peptide-Based Vaccines Research Group, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Budapest 1117, Hungary.ORCID 0000-0003-4092-6011
Eötvös Loránd University · HUMedical University of Graz · ATNational Institute of Oncology · HUSt George's, University of London · GBInstitute of Materials and Environmental Chemistry · HUUniversity of Veterinary Medicine · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complex immunopathology of

Indexed as

Mycobacterium tuberculosisTuberculosisTuberculosis VaccinesAnimalsAntigens, BacterialCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesEpitopes, T-LymphocyteHumansLeukocytes, MononuclearMicePeptidesAntigens, BacterialEpitopes, T-LymphocytePeptidesTuberculosis Vaccines

Identifiers

PMID37606258
PMCPMC10587871
OpenAlexW4386047070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.